We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Pgnx Capital Corporation | TSXV:PGN | TSX Venture | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0 | - |
Paragon Pharmacies Limited ("Paragon" or "the Company") (TSX VENTURE:PGN) today announced the appointment of Mr. Eric Stefanson, FCA, to the Company's Board of Directors. The appointment is subject to the approval of the TSX Venture Exchange. Martin Weinberg, Chairman of the Board of Directors, notes, "I am pleased Eric has agreed to serve on Paragon's Board. Eric's vast business acumen will provide further expertise to an already strongly represented Board. Eric's participation is expected to bring additional insight into the strategic direction of the Company and we look forward to his involvement." Mr. Stefanson, an independent director, achieved his Chartered Accountant (CA) degree in 1975 and subsequently received his Fellow of the Chartered Accountants (FCA) in 1991. From 1978 to 1990 Mr. Stefanson was a partner in Stefanson and Lee, a local chartered accountancy firm in Manitoba. He was Managing Partner of the Central Canada Region (CCR) for BDO Canada LLP Chartered Accountants and Advisors from 2004 to 2009 where he was responsible for the CCR operations, providing leadership and direction. Further, Mr. Stefanson's career has included serving as Chief Financial Officer and Managing Director, Finance and Planning for Assante Canada from April 2001 to January 2004. From November 1999 to April 2001 he was the Chief Operating Officer for Assante Asset Management Ltd. From 1990 to 2000, Mr. Stefanson served as a Member of the Legislative Assembly for the Province of Manitoba. During that time, Mr. Stefanson served in many capacities including the Minister of Health and Deputy Premier. He also served as the Minister of Finance, Minister charged with the administration of the Crown Corporation's Public Review and Accountability Act, chair of the Treasury Board, the Minister of Industry, Trade and Tourism and Minister responsible for Sport, charged with the administration of the Boxing Commission Act, and the Fitness and Amateur Sport Act. From 1982 to 1989 Mr. Stefanson served the City of Winnipeg as councillor and was Deputy Mayor from 1986 to 1988. Other community involvement activities include serving as Chairman of the Winnipeg 2000 Task Force on Economic Development, President of the Winnipeg Convention Centre, officer of the Red River Exhibition Association and member of the Board of Directors of the North Portage Development Corporation. In August 2000 Mr. Stefanson received the Icelandic Order of the Falcon from the President of Iceland. Mr. Stefanson is currently a member of the Board of Directors for the Winnipeg Foundation (Chair of Audit Committee), Via Rail Canada (Chair of Audit Committee), FWS Holdings Ltd. (Chair of Audit Committee), Canada West Foundation and the Health Sciences Centre Foundation (Chair of Board) as well as Chair of the Investment Committee of the Winnipeg Civic Employees' Benefits Program. Paragon Pharmacies Limited is building a pharmacy with our customers in mind. Headquartered in Kelowna, BC and employing over 400 staff, Paragon currently owns and operates 19 retail pharmacies and three central fill pharmacies throughout British Columbia, Alberta and Manitoba. Paragon is a leading mid-market pharmacy, providing premier pharmacy services in a friendly, community-focused environment. FORWARD LOOKING STATEMENTS This press release may contain forward-looking statements regarding, among other things, the Company's beliefs, plans, objectives, strategies, estimates, intentions and expectations, including as they relate to its operating and financial results, capital expenditures and the ability to execute on its operating, investing and financing strategies. Consequently, actual results and events may differ materially from those included in, contemplated or implied by such forward looking statements for a variety of reasons. Forward-looking statements are subject to inherent risks and uncertainties including, but not limited to, market and general economic conditions, certain property and casualty risks, the ability to attract and retain pharmacists, the availability and terms of financing, changes in the Company's relationship with its key suppliers, competitive factors, changes in regulatory environments affecting the Company's business, and the accuracy in management's assumptions (see "RISKS AND RISK MANAGEMENT" as noted in the Company's Management's Discussion & Analysis posted on SEDAR at www.sedar.com). This list is not exhaustive of the factors that may affect any of the Company's forward-looking statements. Investors and others should carefully consider these and other factors and not place undue reliance on these forward-looking statements. In addition, these forward-looking statements relate to the date on which they were made and the Company disclaims and has no intention or obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.
1 Year Pgnx Capital Corporation Chart |
1 Month Pgnx Capital Corporation Chart |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions